H.R. 2069 — Neuromyelitis Optica Consortium Act

Summary

Neuromyelitis Optica Consortium Act

This bill amends the Public Health Service Act to require the National Institutes of Health to establish, administer, and coordinate a National Neuromyelitis Optica (NMO) Consortium to:

award grants for research on the causes of, and the risk factors and biomarkers associated with, NMO (a neurological disease leading to blindness and paralysis);
assemble a panel of experts to provide ongoing guidance and recommendations on research design and protocols; and
designate a central laboratory to collect, analyze, and aggregate data from this research and to make the data and analysis available to researchers.

Full Text

Legislative Actions

2015-04-28
Introduced in House
2015-04-28
Introduced in House
2015-04-28
Referred to the House Committee on Energy and Commerce.
2015-05-01
Referred to the Subcommittee on Health.

Neuromyelitis Optica Consortium Act

Sponsors

Subjects

Summary

Full Text

Legislative Actions

Ask about this bill